Skip to main content
Chison Medical Technologies Co.,Ltd. logo

Chison Medical Technologies Co.,Ltd. — Investor Relations & Filings

Ticker · 688358 ISIN · CNE1000076R4 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 686 across all filing types
Latest filing 2021-04-23 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688358

About Chison Medical Technologies Co.,Ltd.

https://www.chison.com/

Chison Medical Technologies Co.,Ltd. specializes in the research, development, and manufacturing of diagnostic ultrasound systems. The company offers a comprehensive portfolio of medical imaging solutions, including trolley-based color Doppler systems, portable ultrasound units, and specialized handheld devices. Its products integrate advanced imaging technologies such as 4D imaging, artificial intelligence-assisted diagnostics, and high-resolution transducers to support clinical applications in cardiology, obstetrics, gynecology, and point-of-care settings. Chison focuses on delivering high-performance diagnostic tools to healthcare providers, supported by a global network of research centers and distribution channels. The company emphasizes continuous innovation in digital signal processing and transducer technology to enhance diagnostic accuracy and clinical workflow efficiency.

Recent filings

Filing Released Lang Actions
国金证券股份有限公司关于无锡祥生医疗科技股份有限公司开展外汇套期保值业务的核查意见
Regulatory Filings Classification · 95% confidence The document is a formal opinion from Guojin Securities Co., Ltd. regarding the verification of Wuxi Xiangsheng Medical Technology Co., Ltd.'s plan to conduct foreign exchange hedging business. It includes legal references, business necessity, risk analysis, risk control measures, and approval procedures. The document is a verification or due diligence opinion related to a specific business activity rather than a financial report, earnings release, or regulatory filing. It does not contain financial statements or quarterly/yearly results. It is also not an announcement of a report publication but a detailed verification opinion. This type of document fits best under Regulatory Filings (RNS) as it is a compliance-related verification opinion that does not fit other specific categories.
2021-04-23 Chinese
容诚会计师事务所（特殊普通合伙）关于无锡祥生医疗科技股份有限公司内部控制审计报告
Audit Report / Information Classification · 95% confidence The document is titled '内部控制审计报告' which translates to 'Internal Control Audit Report'. It is issued by a certified public accounting firm and addresses the effectiveness of internal controls over financial reporting as of December 31, 2020. The content includes auditor responsibilities, company responsibilities, and an audit opinion on internal control effectiveness. The document length is 1196 characters, indicating it is a standalone audit report rather than a full annual report or other comprehensive financial report. There is no indication that this is an announcement or certification letter only. Therefore, this document fits the category of an Audit Report / Information (AR). FY 2020
2021-04-23 Chinese
祥生医疗第二届监事会第四次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed by the Supervisory Board of Wuxi Xiangsheng Medical Technology Co., Ltd. It references multiple reports and proposals related to the 2020 annual report, profit distribution, financial statements, internal control evaluation, and the 2021 first quarter report. The document includes voting results and states that these matters will be submitted to the 2020 annual shareholders' meeting for approval. The document itself is not the full annual report or quarterly report but an official announcement of the Supervisory Board's meeting decisions and approvals. It is a formal disclosure of board/management information regarding supervisory board resolutions and approvals, not the reports themselves or their publication announcements. Therefore, the best fitting category is Board/Management Information (MANG). The document length (4573 characters) supports it being a detailed announcement rather than a brief publication notice.
2021-04-23 Chinese
祥生医疗关于2020年年度利润分配方案的公告
Notice of Dividend Amount Classification · 95% confidence The document is an announcement regarding the 2020 annual profit distribution plan of Wuxi Xiangsheng Medical Technology Co., Ltd. It details the dividend per share, total dividend amount, and the approval process including board and supervisory committee meetings. The document does not contain full financial statements or comprehensive financial performance data but focuses on the dividend distribution plan and related approvals. It is not a full annual report or interim report but a specific announcement about dividend distribution. This fits the definition of a Notice of Dividend Amount (DIV). The document length is 1873 characters, which is consistent with an announcement rather than a full report.
2021-04-23 Chinese
容诚会计师事务所（特殊普通合伙）关于无锡祥生医疗科技股份有限公司2020年度审计报告
Audit Report / Information Classification · 100% confidence The document is titled '审计报告' which translates to 'Audit Report'. It is issued by an accounting firm (容诚会计师事务所) and addresses the shareholders of 无锡祥生医疗科技股份有限公司. The content includes an auditor's opinion on the financial statements for the year ended December 31, 2020, detailed audit procedures, responsibilities of management and auditors, and key audit matters. It also contains detailed financial statements such as the consolidated balance sheet and profit statement. The document is about 15,000 characters long, indicating it is a full report rather than a brief announcement. The presence of detailed audit opinions and financial data confirms this is a standalone audit report, not an annual report or other filing type. Therefore, the correct classification is Audit Report / Information (AR). FY 2020
2021-04-23 Chinese
祥生医疗独立董事关于第二届董事会第四次会议相关议案的独立意见
Board/Management Information Classification · 95% confidence The document is an independent director's opinion on various proposals discussed at the company's second board's fourth meeting. It covers topics such as the 2021 remuneration plan for directors and senior management, appointment of the 2021 audit firm, 2020 profit distribution plan, use of raised funds, expected related party transactions, accounting policy changes, stock incentive plans, and other governance matters. The document references the 2020 annual shareholders' meeting for approval of these proposals. It is not a full annual report or audit report but rather an opinion on board meeting proposals, including remuneration and governance issues. This fits best under Board/Management Information (MANG) as it relates to board meeting proposals and independent director opinions on management and governance matters.
2021-04-23 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.